The results obtained in this study provide evidence that PLD2 in CD8+ T lymphocytes plays an important role in the TCR-mediated proliferation of these cells in the spleen by regulating the Ras-Erk signaling pathway and IL-2 production, thereby at least in part contributing to the anti-tumor immunity. This evidence concerns the gene CD8A and neoplasm.